CRH Medical Co. (TSE:CRH) – Equities researchers at Cormark reduced their FY2017 EPS estimates for shares of CRH Medical in a research report issued on Thursday, according to Zacks Investment Research. Cormark analyst D. Novak now anticipates that the company will post earnings per share of $0.15 for the year, down from their prior forecast of $0.17. Cormark also issued estimates for CRH Medical’s Q4 2017 earnings at $0.09 EPS, Q1 2018 earnings at $0.04 EPS, Q4 2018 earnings at $0.06 EPS and FY2018 earnings at $0.22 EPS.
Several other equities analysts also recently commented on the company. National Bank Financial cut their target price on CRH Medical from C$5.25 to C$4.25 and set an “outperform” rating for the company in a research report on Monday, November 6th. TD Securities cut their price objective on CRH Medical from C$3.25 to C$2.50 and set a “hold” rating for the company in a research report on Monday, November 6th. Scotiabank cut their price objective on CRH Medical from C$6.00 to C$4.25 and set an “outperform” rating for the company in a research report on Friday, November 3rd. Royal Bank Of Canada cut their price objective on CRH Medical from C$5.00 to C$4.50 and set an “outperform” rating for the company in a research report on Thursday, November 2nd. Finally, Beacon Securities downgraded CRH Medical from a “buy” rating to a “hold” rating in a research report on Thursday, August 3rd. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of C$3.88.
CRH Medical (TSE:CRH) opened at C$1.92 on Monday. CRH Medical has a 52-week low of C$1.91 and a 52-week high of C$12.35.
About CRH Medical
CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CRH Medical Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Co. and related companies with MarketBeat.com's FREE daily email newsletter.